Guoying Yu

4.3k total citations
89 papers, 2.5k citations indexed

About

Guoying Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Guoying Yu has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 27 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Guoying Yu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Pulmonary Hypertension Research and Treatments (21 papers) and MicroRNA in disease regulation (13 papers). Guoying Yu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Pulmonary Hypertension Research and Treatments (21 papers) and MicroRNA in disease regulation (13 papers). Guoying Yu collaborates with scholars based in China, United States and Russia. Guoying Yu's co-authors include Naftali Kaminski, George K. Michalopoulos, Kathleen Cieply, George C. Tseng, Kusum Pandit, Kevin F. Gibson, Iván O. Rosas, Lan Wang, Bingyu Ye and Qiwen Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Guoying Yu

81 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoying Yu China 27 1.1k 1.0k 584 256 216 89 2.5k
Anne M. Manicone United States 23 712 0.7× 699 0.7× 448 0.8× 646 2.5× 308 1.4× 39 2.2k
Gonzalo Sánchez‐Duffhues Netherlands 26 1.2k 1.1× 424 0.4× 289 0.5× 272 1.1× 238 1.1× 51 2.4k
Yun Huang China 24 1.4k 1.3× 460 0.4× 617 1.1× 303 1.2× 388 1.8× 53 2.1k
Randolph A. Hennigar United States 23 1.2k 1.1× 527 0.5× 729 1.2× 210 0.8× 199 0.9× 49 2.5k
Carlos Ramos Mexico 25 680 0.6× 1.5k 1.5× 371 0.6× 193 0.8× 325 1.5× 65 2.5k
Fei Gao China 29 1.2k 1.1× 333 0.3× 448 0.8× 569 2.2× 228 1.1× 114 2.6k
Tomás P. Carroll Ireland 22 547 0.5× 725 0.7× 808 1.4× 395 1.5× 485 2.2× 59 2.0k
Lars C. Petersen Denmark 31 951 0.9× 456 0.4× 737 1.3× 334 1.3× 307 1.4× 93 3.6k
Fumitaka Ogushi Japan 25 547 0.5× 718 0.7× 447 0.8× 365 1.4× 453 2.1× 116 2.1k
Kamal A. Mohammed United States 27 508 0.5× 793 0.8× 191 0.3× 299 1.2× 234 1.1× 58 1.7k

Countries citing papers authored by Guoying Yu

Since Specialization
Citations

This map shows the geographic impact of Guoying Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoying Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoying Yu more than expected).

Fields of papers citing papers by Guoying Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoying Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoying Yu. The network helps show where Guoying Yu may publish in the future.

Co-authorship network of co-authors of Guoying Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoying Yu. A scholar is included among the top collaborators of Guoying Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoying Yu. Guoying Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lingli, et al.. (2025). Lead exposure disrupts cytoskeletal arrangement and perturbs glucose metabolism in nerve cells through activation of the RhoA/ROCK signaling pathway. Journal of Trace Elements in Medicine and Biology. 89. 127663–127663.
2.
3.
Wan, Ruyan, et al.. (2024). Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts. Life Science Alliance. 8(2). e202402805–e202402805. 2 indexed citations
4.
Yang, Juntang, Xin Pan, Min Xu, et al.. (2024). Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts. Respiratory Research. 25(1). 176–176. 7 indexed citations
5.
6.
Wang, Cui, et al.. (2023). Antibacterial and immunoregulatory activity of an antimicrobial peptide hepcidin in loach (Misgurnus anguillicaudatus). International Journal of Biological Macromolecules. 242(Pt 2). 124833–124833. 12 indexed citations
7.
Yang, Juntang, Chenxi Liang, Lulu Liu, Lan Wang, & Guoying Yu. (2023). High-Fat Diet Related Lung Fibrosis-Epigenetic Regulation Matters. Biomolecules. 13(3). 558–558. 7 indexed citations
8.
Wang, Lan, Cong Xia, Zhongzheng Li, et al.. (2023). TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences. 81(1). 13–13. 3 indexed citations
9.
Xu, Kai, Yanan Hu, Yuexia Yang, et al.. (2023). Tuftelin1 drives experimental pulmonary fibrosis progression by facilitating stress fiber assembly. Respiratory Research. 24(1). 318–318. 6 indexed citations
10.
Wang, Gaiping, et al.. (2023). Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis. Biomolecules. 13(6). 940–940. 6 indexed citations
11.
Liu, Jingyi, et al.. (2023). Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung. International Journal of Molecular Sciences. 25(1). 315–315. 28 indexed citations
12.
Wang, Qiwen, et al.. (2019). <p>Overview of microRNA-199a Regulation in Cancer</p>. Cancer Management and Research. Volume 11. 10327–10335. 57 indexed citations
13.
Tzouvelekis, Argyrios, Guoying Yu, Christian L. Lino Cardenas, et al.. (2016). SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 195(4). 500–514. 41 indexed citations
14.
Montgomery, Rusty L., Guoying Yu, Christianna Stack, et al.. (2014). Micro RNA mimicry blocks pulmonary fibrosis. EMBO Molecular Medicine. 6(10). 1347–1356. 184 indexed citations
15.
Yu, Guoying, Jose D. Herazo‐Maya, Tomoko Nukui, et al.. (2014). Matrix Metalloproteinase-19 Promotes Metastatic Behavior In Vitro and is Associated with Increased Mortality in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 190(7). 780–790. 52 indexed citations
16.
Shi, Yuanyuan, Bernadette R. Gochuico, Guoying Yu, et al.. (2013). Syndecan-2 Exerts Antifibrotic Effects by Promoting Caveolin-1–mediated Transforming Growth Factor-β Receptor I Internalization and Inhibiting Transforming Growth Factor-β1 Signaling. American Journal of Respiratory and Critical Care Medicine. 188(7). 831–841. 45 indexed citations
17.
Milošević, Jadranka, Kusum Pandit, Daniel C. Ellwanger, et al.. (2012). Profibrotic Role of miR-154 in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 47(6). 879–887. 142 indexed citations
18.
Yu, Guoying, Anil V. Parwani, Daniel J. Kass, et al.. (2012). Matrix Metalloproteinase-19 Is a Key Regulator of Lung Fibrosis in Mice and Humans. American Journal of Respiratory and Critical Care Medicine. 186(8). 752–762. 82 indexed citations
19.
Yamashita, Cory, Rachel L. Zemans, Scott K. Young, et al.. (2011). Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis. American Journal Of Pathology. 179(4). 1733–1745. 162 indexed citations
20.
Yu, Yan, Guoying Yu, George C. Tseng, et al.. (2007). Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis. Cancer Research. 67(17). 8043–8050. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Manicone Breakdown of academic impact, for papers by Gonzalo Sánchez‐Duffhues Breakdown of academic impact, for papers by Yun Huang Breakdown of academic impact, for papers by Randolph A. Hennigar Breakdown of academic impact, for papers by Carlos Ramos Breakdown of academic impact, for papers by Fei Gao Breakdown of academic impact, for papers by Tomás P. Carroll Breakdown of academic impact, for papers by Lars C. Petersen Breakdown of academic impact, for papers by Fumitaka Ogushi Breakdown of academic impact, for papers by Kamal A. Mohammed
Rankless by CCL
2026